Cukierman & Co. Life Sciences (CLS) provides services to companies across the Life Sciences spectrum including biotechnology, pharmaceuticals, medical devices and e-health technologies.
Established in 2006 as the Life Sciences Corporate Finance arm of Cukierman & Co, CLS offers investment banking services to private and public companies at different stages of their development cycle. CLS has been engaged in an increasing number of successful Private Placements and more recently IPOs, in Europe, US and China.
Our mission :
- Assisting life sciences companies in identifying, negotiating and closing equity and debt financings, licensing agreements, strategic partnerships, M&A transactions.
- Supporting investors and funds in selecting, evaluating, acquiring and divesting assets, businesses and companies in all life sciences sectors.
Our extensive international industry relationships as well as our finance, business and scientific background, generate creative ideas and sound solutions for the demands that characterize the life sciences industry.